Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study. COVIDSurg Collaborative & GlobalSurg Collaborative Anaesthesia, 76(6):748–758, 2021. _eprint: https://onlinelibrary.wiley.com/doi/pdf/10.1111/anae.15458![Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study [link]](https://bibbase.org/img/filetypes/link.svg "link")
Paper doi abstract bibtex Peri-operative SARS-CoV-2 infection increases postoperative mortality. The aim of this study was to determine the optimal duration of planned delay before surgery in patients who have had SARS-CoV-2 infection. This international, multicentre, prospective cohort study included patients undergoing elective or emergency surgery during October 2020. Surgical patients with pre-operative SARS-CoV-2 infection were compared with those without previous SARS-CoV-2 infection. The primary outcome measure was 30-day postoperative mortality. Logistic regression models were used to calculate adjusted 30-day mortality rates stratified by time from diagnosis of SARS-CoV-2 infection to surgery. Among 140,231 patients (116 countries), 3127 patients (2.2%) had a pre-operative SARS-CoV-2 diagnosis. Adjusted 30-day mortality in patients without SARS-CoV-2 infection was 1.5% (95%CI 1.4–1.5). In patients with a pre-operative SARS-CoV-2 diagnosis, mortality was increased in patients having surgery within 0–2 weeks, 3–4 weeks and 5–6 weeks of the diagnosis (odds ratio (95%CI) 4.1 (3.3–4.8), 3.9 (2.6–5.1) and 3.6 (2.0–5.2), respectively). Surgery performed ≥ 7 weeks after SARS-CoV-2 diagnosis was associated with a similar mortality risk to baseline (odds ratio (95%CI) 1.5 (0.9–2.1)). After a ≥ 7 week delay in undertaking surgery following SARS-CoV-2 infection, patients with ongoing symptoms had a higher mortality than patients whose symptoms had resolved or who had been asymptomatic (6.0% (95%CI 3.2–8.7) vs. 2.4% (95%CI 1.4–3.4) vs. 1.3% (95%CI 0.6–2.0), respectively). Where possible, surgery should be delayed for at least 7 weeks following SARS-CoV-2 infection. Patients with ongoing symptoms ≥ 7 weeks from diagnosis may benefit from further delay.
@article{covidsurg_collaborative_timing_2021,
title = {Timing of surgery following {SARS}-{CoV}-2 infection: an international prospective cohort study},
volume = {76},
copyright = {© 2021 The Authors. Anaesthesia published by John Wiley \& Sons Ltd on behalf of Association of Anaesthetists.},
issn = {1365-2044},
shorttitle = {Timing of surgery following {SARS}-{CoV}-2 infection},
url = {https://onlinelibrary.wiley.com/doi/abs/10.1111/anae.15458},
doi = {10.1111/anae.15458},
abstract = {Peri-operative SARS-CoV-2 infection increases postoperative mortality. The aim of this study was to determine the optimal duration of planned delay before surgery in patients who have had SARS-CoV-2 infection. This international, multicentre, prospective cohort study included patients undergoing elective or emergency surgery during October 2020. Surgical patients with pre-operative SARS-CoV-2 infection were compared with those without previous SARS-CoV-2 infection. The primary outcome measure was 30-day postoperative mortality. Logistic regression models were used to calculate adjusted 30-day mortality rates stratified by time from diagnosis of SARS-CoV-2 infection to surgery. Among 140,231 patients (116 countries), 3127 patients (2.2\%) had a pre-operative SARS-CoV-2 diagnosis. Adjusted 30-day mortality in patients without SARS-CoV-2 infection was 1.5\% (95\%CI 1.4–1.5). In patients with a pre-operative SARS-CoV-2 diagnosis, mortality was increased in patients having surgery within 0–2 weeks, 3–4 weeks and 5–6 weeks of the diagnosis (odds ratio (95\%CI) 4.1 (3.3–4.8), 3.9 (2.6–5.1) and 3.6 (2.0–5.2), respectively). Surgery performed ≥ 7 weeks after SARS-CoV-2 diagnosis was associated with a similar mortality risk to baseline (odds ratio (95\%CI) 1.5 (0.9–2.1)). After a ≥ 7 week delay in undertaking surgery following SARS-CoV-2 infection, patients with ongoing symptoms had a higher mortality than patients whose symptoms had resolved or who had been asymptomatic (6.0\% (95\%CI 3.2–8.7) vs. 2.4\% (95\%CI 1.4–3.4) vs. 1.3\% (95\%CI 0.6–2.0), respectively). Where possible, surgery should be delayed for at least 7 weeks following SARS-CoV-2 infection. Patients with ongoing symptoms ≥ 7 weeks from diagnosis may benefit from further delay.},
language = {en},
number = {6},
urldate = {2024-09-20},
journal = {Anaesthesia},
author = {{COVIDSurg Collaborative} and {GlobalSurg Collaborative}},
year = {2021},
note = {\_eprint: https://onlinelibrary.wiley.com/doi/pdf/10.1111/anae.15458},
keywords = {COVID-19, SARS-CoV-2, delay, surgery, timing},
pages = {748--758},
}
Downloads: 0
{"_id":"MTQw4dXDjRHMZg2Qw","bibbaseid":"covidsurgcollaborative-globalsurgcollaborative-timingofsurgeryfollowingsarscov2infectionaninternationalprospectivecohortstudy-2021","authorIDs":["xsvDNXvL2eLvMdLP6"],"author_short":["COVIDSurg Collaborative","GlobalSurg Collaborative"],"bibdata":{"bibtype":"article","type":"article","title":"Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study","volume":"76","copyright":"© 2021 The Authors. Anaesthesia published by John Wiley & Sons Ltd on behalf of Association of Anaesthetists.","issn":"1365-2044","shorttitle":"Timing of surgery following SARS-CoV-2 infection","url":"https://onlinelibrary.wiley.com/doi/abs/10.1111/anae.15458","doi":"10.1111/anae.15458","abstract":"Peri-operative SARS-CoV-2 infection increases postoperative mortality. The aim of this study was to determine the optimal duration of planned delay before surgery in patients who have had SARS-CoV-2 infection. This international, multicentre, prospective cohort study included patients undergoing elective or emergency surgery during October 2020. Surgical patients with pre-operative SARS-CoV-2 infection were compared with those without previous SARS-CoV-2 infection. The primary outcome measure was 30-day postoperative mortality. Logistic regression models were used to calculate adjusted 30-day mortality rates stratified by time from diagnosis of SARS-CoV-2 infection to surgery. Among 140,231 patients (116 countries), 3127 patients (2.2%) had a pre-operative SARS-CoV-2 diagnosis. Adjusted 30-day mortality in patients without SARS-CoV-2 infection was 1.5% (95%CI 1.4–1.5). In patients with a pre-operative SARS-CoV-2 diagnosis, mortality was increased in patients having surgery within 0–2 weeks, 3–4 weeks and 5–6 weeks of the diagnosis (odds ratio (95%CI) 4.1 (3.3–4.8), 3.9 (2.6–5.1) and 3.6 (2.0–5.2), respectively). Surgery performed ≥ 7 weeks after SARS-CoV-2 diagnosis was associated with a similar mortality risk to baseline (odds ratio (95%CI) 1.5 (0.9–2.1)). After a ≥ 7 week delay in undertaking surgery following SARS-CoV-2 infection, patients with ongoing symptoms had a higher mortality than patients whose symptoms had resolved or who had been asymptomatic (6.0% (95%CI 3.2–8.7) vs. 2.4% (95%CI 1.4–3.4) vs. 1.3% (95%CI 0.6–2.0), respectively). Where possible, surgery should be delayed for at least 7 weeks following SARS-CoV-2 infection. Patients with ongoing symptoms ≥ 7 weeks from diagnosis may benefit from further delay.","language":"en","number":"6","urldate":"2024-09-20","journal":"Anaesthesia","author":[{"firstnames":[],"propositions":[],"lastnames":["COVIDSurg Collaborative"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["GlobalSurg Collaborative"],"suffixes":[]}],"year":"2021","note":"_eprint: https://onlinelibrary.wiley.com/doi/pdf/10.1111/anae.15458","keywords":"COVID-19, SARS-CoV-2, delay, surgery, timing","pages":"748–758","bibtex":"@article{covidsurg_collaborative_timing_2021,\n\ttitle = {Timing of surgery following {SARS}-{CoV}-2 infection: an international prospective cohort study},\n\tvolume = {76},\n\tcopyright = {© 2021 The Authors. Anaesthesia published by John Wiley \\& Sons Ltd on behalf of Association of Anaesthetists.},\n\tissn = {1365-2044},\n\tshorttitle = {Timing of surgery following {SARS}-{CoV}-2 infection},\n\turl = {https://onlinelibrary.wiley.com/doi/abs/10.1111/anae.15458},\n\tdoi = {10.1111/anae.15458},\n\tabstract = {Peri-operative SARS-CoV-2 infection increases postoperative mortality. The aim of this study was to determine the optimal duration of planned delay before surgery in patients who have had SARS-CoV-2 infection. This international, multicentre, prospective cohort study included patients undergoing elective or emergency surgery during October 2020. Surgical patients with pre-operative SARS-CoV-2 infection were compared with those without previous SARS-CoV-2 infection. The primary outcome measure was 30-day postoperative mortality. Logistic regression models were used to calculate adjusted 30-day mortality rates stratified by time from diagnosis of SARS-CoV-2 infection to surgery. Among 140,231 patients (116 countries), 3127 patients (2.2\\%) had a pre-operative SARS-CoV-2 diagnosis. Adjusted 30-day mortality in patients without SARS-CoV-2 infection was 1.5\\% (95\\%CI 1.4–1.5). In patients with a pre-operative SARS-CoV-2 diagnosis, mortality was increased in patients having surgery within 0–2 weeks, 3–4 weeks and 5–6 weeks of the diagnosis (odds ratio (95\\%CI) 4.1 (3.3–4.8), 3.9 (2.6–5.1) and 3.6 (2.0–5.2), respectively). Surgery performed ≥ 7 weeks after SARS-CoV-2 diagnosis was associated with a similar mortality risk to baseline (odds ratio (95\\%CI) 1.5 (0.9–2.1)). After a ≥ 7 week delay in undertaking surgery following SARS-CoV-2 infection, patients with ongoing symptoms had a higher mortality than patients whose symptoms had resolved or who had been asymptomatic (6.0\\% (95\\%CI 3.2–8.7) vs. 2.4\\% (95\\%CI 1.4–3.4) vs. 1.3\\% (95\\%CI 0.6–2.0), respectively). Where possible, surgery should be delayed for at least 7 weeks following SARS-CoV-2 infection. Patients with ongoing symptoms ≥ 7 weeks from diagnosis may benefit from further delay.},\n\tlanguage = {en},\n\tnumber = {6},\n\turldate = {2024-09-20},\n\tjournal = {Anaesthesia},\n\tauthor = {{COVIDSurg Collaborative} and {GlobalSurg Collaborative}},\n\tyear = {2021},\n\tnote = {\\_eprint: https://onlinelibrary.wiley.com/doi/pdf/10.1111/anae.15458},\n\tkeywords = {COVID-19, SARS-CoV-2, delay, surgery, timing},\n\tpages = {748--758},\n}\n\n","author_short":["COVIDSurg Collaborative","GlobalSurg Collaborative"],"key":"covidsurg_collaborative_timing_2021","id":"covidsurg_collaborative_timing_2021","bibbaseid":"covidsurgcollaborative-globalsurgcollaborative-timingofsurgeryfollowingsarscov2infectionaninternationalprospectivecohortstudy-2021","role":"author","urls":{"Paper":"https://onlinelibrary.wiley.com/doi/abs/10.1111/anae.15458"},"keyword":["COVID-19","SARS-CoV-2","delay","surgery","timing"],"metadata":{"authorlinks":{"wong, d":"https://dannyjnwong.github.io/"}},"downloads":0},"bibtype":"article","biburl":"https://api.zotero.org/users/1188758/collections/WJHTC5UZ/items?key=7QzWTTX0ysbCCy2IG4B2maFv&format=bibtex&limit=100","creationDate":"2021-03-10T23:12:24.009Z","downloads":0,"keywords":["covid-19","sars-cov-2","delay","surgery","timing"],"search_terms":["timing","surgery","following","sars","cov","infection","international","prospective","cohort","study","covidsurg collaborative","globalsurg collaborative"],"title":"Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study","year":2021,"dataSources":["PkLMYCghAEnwtJn2Z","CGbsLwcGoQo3gPyW2","jPo8HeJvKpk6knJoB","h79CQ9k2QjDG2ekzW","K4FrjNapLHnxPFpcy","32QNazyfKrHT3HRxT","gNMTX4odsYuhpBcQE","XGWqaNGNxt7LcxA5A","rNrGm9qAe2vZyEs6x"]}